Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Total-Capital" stands at 20.08 percent as of 09/30/2025, the highest value since 09/30/2024.
As of the end of Johnson & Johnson's third quarter, the item "Return On Total Capital" stands at 20.08 Percent. This represents an increase of 2.55 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.22 percentage points compared to the value the year prior.
The 1 year change in percentage points is 6.22.
The 3 year change in percentage points is 2.12.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Total Capital | 905,699,262,464.00 |
![]() | AbbVie Inc - Return On Total Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Total Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Total Capital | 280,205,508,085.11 |
![]() | Novartis AG - Return On Total Capital | 255,096,620,580.91 |